Fundz

AdvanCell Appoints Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer

PRIVATEJun 08, 2026

Position

Chief Scientific Officer

Company

AdvanCell

François Gaudet
SydneyBiotechnologyHealth CareTherapeutics

Description

AdvanCell has announced the appointments of Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer to enhance its executive leadership team. This move is part of the company’s strategy to accelerate its U.S. expansion and strengthen its targeted alpha therapy platform.

Quick answer

AdvanCell Appoints Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer (June 8, 2026). AdvanCell is based in Sydney, New South Wales, Australia.

Who is the new Chief Scientific Officer at AdvanCell?
AdvanCell named François Gaudet Chief Scientific Officer, announced June 8, 2026.
What did AdvanCell announce on June 8, 2026?
AdvanCell has announced the appointments of Justyna Kelly as Chief Technology Officer and François Gaudet as Chief Scientific Officer to enhance its executive leadership team. This move is part of the company’s strategy to accelerate its U.S. expansion and strengthen its targeted alpha therapy platform.
What does AdvanCell do?
AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides.
Where is AdvanCell based?
AdvanCell is based in Sydney, New South Wales, Australia.
Which similar companies made leadership changes around the same time?
Lakefront Biotherapeutics NV (June 8, 2026), Vergent Bioscience (June 9, 2026), MitoRx Therapeutics (June 9, 2026) and Poxel (June 10, 2026) also announced leadership changes within 45 days of AdvanCell.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AdvanCell, and when

A new leader at AdvanCell brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AdvanCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AdvanCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AdvanCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AdvanCell

Location

Macquarie Street

Sydney, New South Wales, Australia

About

AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company dedicated to developing innovative cancer therapies that harness the power of targeted alpha-emitting radionuclides. By leveraging its proprietary Lead-212 platform, advanced and scalable manufacturing capabilities and world-class clinical development capabilities, AdvanCell aims to deliver novel treatments that improve outcomes for patients with cancer globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AdvanCell changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Andrew
Senior decision-maker at this company
••••••••@••••••••

See Andrew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AdvanCell's next move

Learn about Strategic plan

AdvanCell changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.